Price to Book Value Chart

View Price to Book Value for DBVT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value Chart
Start Trial

Historical Price to Book Value Data

View and export this data back to 2021. Start Trial.
Date Value
August 21, 2026 4.142
August 20, 2026 4.054
August 19, 2026 4.207
August 18, 2026 4.119
August 17, 2026 4.176
August 14, 2026 3.991
August 13, 2026 3.994
August 12, 2026 4.025
August 11, 2026 4.011
August 10, 2026 4.062
August 07, 2026 3.837
August 06, 2026 3.911
August 05, 2026 4.054
August 04, 2026 3.903
August 03, 2026 3.866
July 31, 2026 3.843
July 30, 2026 3.931
July 29, 2026 3.908
July 28, 2026 3.843
July 27, 2026 3.957
July 24, 2026 3.880
July 23, 2026 3.946
July 22, 2026 3.880
July 21, 2026 4.048
July 20, 2026 4.148
Date Value
July 17, 2026 4.185
July 16, 2026 4.230
July 15, 2026 4.472
July 14, 2026 4.532
July 13, 2026 4.549
July 10, 2026 4.694
July 09, 2026 4.578
July 08, 2026 4.768
July 07, 2026 4.939
July 06, 2026 4.444
July 02, 2026 4.504
July 01, 2026 4.478
June 30, 2026 4.669
June 29, 2026 4.555
June 26, 2026 4.558
June 25, 2026 4.560
June 24, 2026 4.441
June 23, 2026 4.586
June 22, 2026 4.469
June 18, 2026 4.421
June 17, 2026 4.634
June 16, 2026 4.768
June 15, 2026 5.158
June 12, 2026 4.958
June 11, 2026 4.708

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Cellectis SA 7.871
Akari Therapeutics Plc 0.7078
EDAP TMS SA --
Autolus Therapeutics Plc 11.13
Evaxion AS 2.940

Price to Book Value Related Metrics

Price 14.05
Earnings Yield -25.01%
Market Cap 831.52M